O: Optomise Function Flashcards

1
Q

Optimise Function: Where to Start

A

Assessment is the First Step. Options:

  • History taking & symptom checklists
  • Validated assessment tool: CAT, or mMRC Dyspnoea Scale
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Best Non-Pharmacological Strategies

A
  • Acute relief: handheld fans, leaning forward
  • Smoking cessation
  • Formal 6-8wk pulmonary rehabilitation program
  • Regular physical activity (150min/wk).

NB: regarding physical activity, instruct them to be active until they feel breathless, take a rest to recover breath, then keep going.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Details on Pulmonary Rehabilitation

A
  • Formalised program run by LFA. Education and exercise program to help patients Mx breathlessness
  • Can re-refer patients for pulmonary rehab if they have since stopped being active and are declining.

NB: After completely pulmonary rehab, patients can attend weekly ‘Lung in Action’ classes at the appropriate LFA-associated community service. It counts towards one’s physical activity requirements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Approach to Pharmacological Therapies

A

Goals (must discuss with patient)

  • Improve symptoms
  • Reduce risk of severe exacerbations & deterioration

Start Low, Work Up in Stepwise Approach

  • 1 long-acting bronchodilator first
  • ^ dose or add another agent if necessary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharmacological Therapy Options

A

Short-Term Relief

  • SABA (salbutamol, terbutaline)
  • SAMA (ipratropium)
  • Note: patients often receive Sx benefit even if no improvement in FEV1

Long-Term (if short-acting relief insufficient to control)

  • LAMA (tiotropium, aclidinium)
  • LABA (salmeterol, indacaterol)
  • Inhaled corticosteroids (fluticasone, budesonide)

NB: Can get combinations as dual therapy if monotherapy can’t control disease. I.e., LABA and LAMA. Can sometimes get as a single inhaler

NB: ^ dose ICS is associated with risk of pneumonia. Limit triple therapy to those who are inadequately controlled by dual therapy

NB: Avoid oral corticosteroid use for any longer than 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When to Review Adherence and Inhaler Technique

A
  • Preferably check at each visit, including inhaler technique, adherence to pharm Mx, and non-pharm strategies

Many Factors Impact Medical Adherence

  • Motivation
  • Understanding of inhaler technique
  • Health literacy
  • Cost of medicines
  • Comorbidities and level of function

If concerned about adherence, consider home medicines review by a pharmacist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When to Refer to Specialist Respiratory Services

A

There are many (here are some)

  • Diagnostic uncertainty
  • Rapid decline in function
  • Poor control despite assumed sufficient therapy
  • Assessment for at-home oxygen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly